Cunning Capital Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-23,640
Closed -$1.66M 80
2024
Q2
$1.66M Hold
23,640
0.93% 51
2024
Q1
$1.75M Hold
23,640
0.97% 50
2023
Q4
$1.56M Hold
23,640
0.97% 58
2023
Q3
$1.49M Buy
+23,640
New +$1.47M 0.98% 55
2023
Q2
Sell
-42,950
Closed -$2.38M 74
2023
Q1
$2.49M Hold
42,950
1.7% 17
2022
Q4
$3.11M Hold
42,950
2.2% 7
2022
Q3
$2.61M Hold
42,950
2.07% 17
2022
Q2
$2.7M Buy
42,950
+19,450
+83% +$1.29M 2.08% 16
2022
Q1
$1.65M Buy
+23,500
New +$1.59M 1.14% 20

Other funds holding MET

Cunning Capital Partners's MET Position: Q3 2024 in Review

Cunning Capital Partners sold out of MetLife (MET) in Q3 2024, closing a stake of 23,640 shares — an estimated $1.66M sold.

Cunning Capital Partners first reported a position in MET in Q1 2022 and held it in 9 quarters. The position peaked at $3.11M in Q4 2022. 1,318 funds tracked by Wall St. Rank hold MET as of Q3 2024.

  • Cunning Capital Partners reported no remaining MetLife position as of Q3 2024 after selling out during the quarter.
  • Cunning Capital Partners sold 23,640 MetLife shares in Q3 2024, an estimated $1.66M.
  • Cunning Capital Partners first reported a position in MetLife in Q1 2022 and held it in 9 quarters.
  • Cunning Capital Partners's MetLife position peaked at $3.11M in Q4 2022.
  • 1,318 funds tracked by Wall St. Rank held MetLife as of Q3 2024.

Based on Cunning Capital Partners's 13F filing for Q3 2024, filed 12 Nov 2024.